|
AMG 337
|
A413926-50mg
|
Moligand™, ≥98% |
1173699-31-4 |
50mg
|
¥ 1759.9
|
现货 |
|
0 |
阿拉丁 |
|
AMG 337
|
A413926-100mg
|
Moligand™, ≥98% |
1173699-31-4 |
100mg
|
¥ 2760.9
|
现货 |
|
0 |
阿拉丁 |
|
BRL 15572 盐酸盐
|
B286655-5mg
|
≥98% |
1173022-77-9 |
5mg
|
¥ 808.9
|
现货 |
|
0 |
阿拉丁 |
|
BRL 15572 盐酸盐
|
B286655-25mg
|
≥98% |
1173022-77-9 |
25mg
|
¥ 2993.9
|
现货 |
|
0 |
阿拉丁 |
|
BRL 15572 盐酸盐
|
B286655-100mg
|
≥98% |
1173022-77-9 |
100mg
|
¥ 7647.9
|
现货 |
|
0 |
阿拉丁 |
|
4-甲基咖啡酸苯乙酯
|
P276401-10mg
|
≥98% |
117292-80-5 |
10mg
|
¥ 298.9
|
现货 |
|
0 |
阿拉丁 |
|
1,2-二甲基-1,1,2,2-四苯基二硅烷
|
D155092-250mg
|
≥98% |
1172-76-5 |
250mg
|
¥ 101.9
|
现货 |
|
0 |
阿拉丁 |
|
叔丁基3-甲基-3H-咪唑[4,5-b] 吡啶-6-氨基甲酸酯
|
T166228-50mg
|
≥98% |
1171920-80-1 |
50mg
|
¥ 751.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
叔丁基3-甲基-3H-咪唑[4,5-b] 吡啶-6-氨基甲酸酯
|
T166228-250mg
|
≥98% |
1171920-80-1 |
250mg
|
¥ 2461.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
7-溴-2-(氯甲基)-1-甲基-1h-咪唑并[4,5-c]吡啶
|
B179819-50mg
|
≥95% |
1171920-75-4 |
50mg
|
¥ 1009.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
7-溴-2-(氯甲基)-1-甲基-1h-咪唑并[4,5-c]吡啶
|
B179819-1g
|
≥95% |
1171920-75-4 |
1g
|
¥ 8116.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
叔丁基(5,6-二甲氧基吡啶-3-基)氨基甲酸甲酯
|
T166199-50mg
|
≥98% |
1171919-86-0 |
50mg
|
¥ 689.9
|
现货 |
|
0 |
阿拉丁 |
|
叔丁基(5,6-二甲氧基吡啶-3-基)氨基甲酸甲酯
|
T166199-250mg
|
≥98% |
1171919-86-0 |
250mg
|
¥ 2412.9
|
现货 |
|
0 |
阿拉丁 |
|
BOC-L-苯甘氨醇
|
B109345-500g
|
≥98% |
117049-14-6 |
500g
|
¥ 1277.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-甲基-N'-(1-(3,4,5-三甲氧基苯基)亚乙基)苯磺酰肼
|
M419570-5g
|
≥97% |
1170045-84-7 |
5g
|
¥ 935.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-甲基-N'-(1-(3,4,5-三甲氧基苯基)亚乙基)苯磺酰肼
|
M419570-25g
|
≥97% |
1170045-84-7 |
25g
|
¥ 3273.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-甲基-N'-(1-(3,4,5-三甲氧基苯基)亚乙基)苯磺酰肼
|
M419570-1g
|
≥97% |
1170045-84-7 |
1g
|
¥ 267.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
AMG 853,双重CRTH2和前列腺素D2(PGD2)受体拮抗剂
|
A286753-5mg
|
Moligand™, ≥98%(HPLC) |
1169483-24-2 |
5mg
|
¥ 1134.9
|
现货 |
|
0 |
阿拉丁 |
|
AMG 853,双重CRTH2和前列腺素D2(PGD2)受体拮抗剂
|
A286753-50mg
|
Moligand™, ≥98%(HPLC) |
1169483-24-2 |
50mg
|
¥ 5172.9
|
现货 |
|
0 |
阿拉丁 |
|
AMG 853,双重CRTH2和前列腺素D2(PGD2)受体拮抗剂
|
A286753-25mg
|
Moligand™, ≥98%(HPLC) |
1169483-24-2 |
25mg
|
¥ 3049.9
|
现货 |
|
0 |
阿拉丁 |
|
AMG 853,双重CRTH2和前列腺素D2(PGD2)受体拮抗剂
|
A286753-100mg
|
Moligand™, ≥98%(HPLC) |
1169483-24-2 |
100mg
|
¥ 8184.9
|
现货 |
|
0 |
阿拉丁 |
|
丙二酰辅酶A四锂盐
|
M332319-5mg
|
≥90% |
116928-84-8 |
5mg
|
¥ 2059.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
丙二酰辅酶A四锂盐
|
M332319-1mg
|
≥90% |
116928-84-8 |
1mg
|
¥ 719.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1-氨基-4-羟基蒽醌
|
A407241-25g
|
≥96% |
116-85-8 |
25g
|
¥ 2599.9
|
现货 |
|
0 |
阿拉丁 |